From what I've been able to ferret out, it seems that partnerships are more likely. COV would actually be using the Radiopharmacological prodcut since they recently divested themselves of that product line.
Could be others that are looking to take advantage of the PET tech.
Sold this AM at .223 when it trended down, back in at .207. Looking for a bit of a run
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.